RTTNews | Oct 4, 2021 08:09AM EDT

08:08 Monday, October 4, 2021 (RTTNews) - RedHill ; Phase 2/3 Data Shows 62% Reduction In Mortality With Oral Opaganib In Moderately Severe COVID-19 Patients

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved